Our Research

Over 30 Years of supporting medical research 

0

 Current active research grants. Over 2000 projects supported since 1987

£0M

Grants awarded by Rosetrees and co-donors since 1987 has led to other major funding approaching £1bn

Our research is focused on 3 key areas – risk and prevention, screening and diagnosis, and treatment of human disease. We aim to fund high-quality translational research that has a clear vision towards patient benefit.

  • We currently fund projects from pre-clinical research exploring molecular mechanisms of human disease through to clinical pilot studies in patients.
  • We fund early career researchers through to more senior investigators up to professors with an established track record. We work with academics, Royal Colleges, philanthropic organisations and businesses to achieve our goals.
  • We meet our researchers throughout their Rosetrees-funded projects to build outstanding, long-term relationships, to improve patients' health and wellbeing.

Special projects

  • As well as medical research, Rosetrees supports a variety of projects that improve the lives of people in their communities. For example, where there was no centre offering advice to early-onset dementia patients and their families on legally entitled benefits, housing, and psychological support, Rosetrees has provided co-funding to set up a unique facility. The initiative was the brainchild of Professor Nick Fox, a dementia specialist at UCL.
  • Rosetrees has also supported the creation of Gesher, a special needs primary school.
  • We have helped fund innovative production ideas at The National Theatre.

Rosetrees News

Genetic changes in tumours could help predict if patients will respond to immunotherapy

February 5, 2021

[et_pb_section fb_built=”1″ _builder_version=”4.5.3″ _module_preset=”default”][et_pb_row _builder_version=”4.5.3″ _module_preset=”default”][et_pb_column type=”4_4″ _builder_version=”4.5.3″ _module_preset=”default”][et_pb_text _builder_version=”4.5.3″ _module_preset=”default”]  Researchers at the Francis Crick Institute, the UCL Cancer…

Genetic changes in tumours could help predict if patients will respond to immunotherapy

February 1, 2021

Genetic changes in tumours could help predict if patients will respond to immunotherapy Researchers at the Francis Crick Institute, the…

ROSETREES ENTERPRISE FELLOWSHIP AWARD

November 17, 2020

ROSETREES ENTERPRISE FELLOWSHIP AWARD We are delighted to announce that Dr Christopher Chapman of Imperial College has been awarded a…